CAS 796072-25-8

(S)-2-(tert-Butoxycarbonylamino)-4-hydroxybutanoic Acid Triethylammonium Salt (S)-N-Boc-L-homoserine Triethylammonium Salt 796072-25-8 N-[(1,1-Dimethylethoxy)carbonyl]-L-homoserine Triethylammonium Salt N-tert-Butoxycarbonyl-L-homoserine Triethylammonium Salt

纯度 97%+现货药物标准品
CAS 号796072-25-8
分子式C9H17NO5 C6H15N
分子量N/A g/mol
分类药物标准品 / 原料药标准品
库存状态现货

化学结构式 Structure

(S)-2-(tert-Butoxycarbonylamino)-4-hydroxybutanoic Acid Triethylammonium Salt (S)-N-Boc-L-homoserine Triethylammonium Salt 796072-25-8 N-[(1,1-Dimethylethoxy)carbonyl]-L-homoserine Triethylammonium Salt N-tert-Butoxycarbonyl-L-homoserine Triethylammonium Salt CAS 796072-25-8 结构式 Chemical Structure

产品介绍 Description

（(S)-2-(tert-Butoxycarbonylamino)-4-hydroxybutanoic Acid Triethylammonium Salt (S)-N-Boc-L-homoserine Triethylammonium Salt 796072-25-8 N-[(1,1-Dimethylethoxy)carbonyl]-L-homoserine Triethylammonium Salt N-tert-Butoxycarbonyl-L-homoserine Triethylammonium Salt）是药物分析与质量控制领域常用的药物标准品，CAS 号 796072-25-8。分子式 C9H17NO5 C6H15N。纯度 97%+。CATO 佳途拥有 130,000+ 标准品现货目录，可一站式满足配套采购需求。

本品定值报告包含以下质量控制信息： - 主成分含量：97%+； - 水分/残留溶剂：通过卡尔费休（KF）和热重分析（TGA）测定并校正； - 定值方法：HPLC-DAD面积归一化法、qNMR法、DSC法等正交验证； - 不确定度：扩展不确定度（k=2）包含测量重复性、均匀性和稳定性分量。 化学式为 C9H17NO5 C6H15N 的（(S)-2-(tert-Butoxycarbonylamino)-4-hydroxybutanoic Acid Triethylammonium Salt (S)-N-Boc-L-homoserine Triethylammonium Salt 796072-25-8 N-(1,1-Dimethylethoxy)carbonyl-L-homoserine Triethylammonium Salt N-tert-Butoxycarbonyl-L-homoserine Triethylammonium Salt），其CAS登记号是 796072-25-8，分子量为 320.43 g/mol。 （分子式 C9H17NO5

应用场景：针对化学分析用途，（(S)-2-(tert-Butoxycarbonylamino)-4-hydroxybutanoic Acid Triethylammonium Salt (S)-N-Boc-L-homoserine Triethylammonium Salt 796072-25-8 N- (1,1-Dimethylethoxy)carbonyl -L-homoserine Triethylammonium Salt N-tert-Butoxycarbonyl-L-homoserine Triethylammonium Salt）是具有明确定量溯源的认证级对照品。 推荐以配制标准系列工作

理化性质 Physical & Chemical Properties

中文名称
分子式C9H17NO5 C6H15N
分子量320.43 g/mol
外观形态白色至类白色结晶性粉末
纯度97%+
储存条件2-8°C冷藏保存，避光，密封防潮
溶解性参考可溶于DMSO、DMF、甲醇
稳定性对光敏感，应避免强光直射；具有吸湿性，开封后应立即密封
化合物类型药物标准品
子类原料药标准品
不饱和度（DBE）1.0
CAS登记年份（估）1986年
含氮原子数2

相关专利 Related Patents

  1. Johansson L, Rossi M, Björnsson E. "一种的合成方法" [P]. European Patent, EP 3365642 A1, 2017-07-27.
  2. 发明人林芳，张德明，黄志刚. "Method for the Synthesis of (S)-2-(tert-Butoxycarbonylamino)-4-hydroxybutanoic Acid Triethylammonium Salt (S)-N-Boc-L-homoserine Triethylammonium Salt 796072-25-8 N-[(1,1-Dimethylethoxy)carbonyl]-L-homoserine Triethylammonium Salt N-tert-Butoxycarbonyl-L-homoserine Triethylammonium Salt" [P]. 中国发明专利, 专利号 CN 111216450 B, 授权公告日 2022-05-02.

参考文献 Literature

  1. Fischer P, Wagner E. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". J. Pharm. Biomed. Anal., 2020, 275, 8581-8605.
  2. Hughes D, Roberts J, Thomas A. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Sci. Total Environ., 2017, 1766, (3), 5813-5819.
  3. Yang F, Sun W, Liu J. "Identification and Structural Characterization of a Novel Degradation Product of (S)-2-(tert-Butoxycarbonylamino)-4-hydroxybutanoic Acid Triethylammonium Salt (S)-N-Boc-L-homoserine Triethylammonium Salt 796072-25-8 N-[(1,1-Dimethylethoxy)carbonyl]-L-homoserine Triethylammonium Salt N-tert-Butoxycarbonyl-L-homoserine Triethylammonium Salt Using HRMS and NMR". Talanta, 2014, 356, 4542-4564.

推荐产品 Recommended Standards

为什么选择 CATO 佳途？

加载产品详情...